Trial Profile
Increased Second-line Eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Conventional Triple Therapy.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Acetylcysteine (Primary) ; Amoxicillin; Clarithromycin; Metronidazole; Rabeprazole
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 16 Apr 2012 New trial record